SAGE Therapeutics ^Investors

SAGE Therapeutics is a prominent accelerator and incubator located in Cambridge, Massachusetts, established in 2010 The organization focuses on advancing innovative therapies for central nervous system disorders With a significant investment scale of $90,000,000, SAGE Therapeutics is dedicated to fostering the development of groundbreaking treatments The company collaborates with leading researchers and institutions to drive scientific progress and improve patient outcomes in the field of neuroscience